semaglutide cardiovascular outcomes 2025 news Study Finds Oral Vastly Reduces Heart Attacks, Strokes Long-Term SELECT Trial: Semaglutide Cuts
Description
2014 May 12

Stimulation of insulin secretion from pancreatic -cells by glucagon-like peptide 1 receptor (GLP-1R) agonists is known to be glucose-dependent

2010;2:52ra73

The team founded Arkana Therapeutics, hoping to develop pTOS-inspired analogs as next-generation therapies for obesity and sarcopenia

Why Do People Stop Taking GLP-1s

The other aspect that differentiates Supergut, according to Washington, is the fact that the company has conducted primary clinical research, which revealed how its shakes can improve HbA1c (a measure of average blood glucose levels), appetite control, weight management (showing a steady decline instead of a massive dropoff), and blood pressure
